Serum Biomarkers Identification by Mass Spectrometry in High-Mortality Tumors

Cancer affects millions of people worldwide. Tumor mortality is substantially due to diagnosis at stages that are too late for therapies to be effective. Advances in screening methods have improved the early diagnosis, prognosis, and survival for some cancers. Several validated biomarkers are curren...

Descripción completa

Detalles Bibliográficos
Autores principales: Tessitore, Alessandra, Gaggiano, Agata, Cicciarelli, Germana, Verzella, Daniela, Capece, Daria, Fischietti, Mariafausta, Zazzeroni, Francesca, Alesse, Edoardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3562576/
https://www.ncbi.nlm.nih.gov/pubmed/23401773
http://dx.doi.org/10.1155/2013/125858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3562576/
https://www.ncbi.nlm.nih.gov/pubmed/23401773
http://dx.doi.org/10.1155/2013/125858

Ejemplares similares